Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration rate (eGFR) of approximately 69 mL/min/1.73 m² ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) today announced third quarter 2025 financial results and provided ...

President Donald Trump’s executive order halting penny production has triggered an urgent scramble across the retail sector.

An investigational triple agonist that targets fibroblast growth factor 21, glucagon and GLP-1 receptors cut triglyceride ...

Gyre Therapeutics ("Gyre") (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...

Short interest is always a sign of how bearish investors may be on a stock. But it can also serve as a potential sign of a coming short squeeze, especially if the stock in question is rocketing higher ...

XRP struggles to stay above $2.15 after failing near $2.35. Analysts warn a drop below key support could trigger a deeper ...

Bitcoin price struggles to rally as a looming bearish cross warns of one last shakeout before recovery can begin.

Roma made short work of Glasgow Rangers at Ibrox, as early Matias Soulé and Lorenzo Pellegrini goals locked down the ...

Solana inflows hit $9.7M in 24 hours as ETFs attract strong institutional demand, boosting bullish sentiment and fueling ...

The Blazpay Token Presale continues to accelerate, crossing the impressive milestone of $940,100 raised with 82.5% of Phase 2 completed. Investors are showing s ...